KR20030035851A - Fungicide composition containing extracts derived from plant - Google Patents

Fungicide composition containing extracts derived from plant Download PDF

Info

Publication number
KR20030035851A
KR20030035851A KR1020020054685A KR20020054685A KR20030035851A KR 20030035851 A KR20030035851 A KR 20030035851A KR 1020020054685 A KR1020020054685 A KR 1020020054685A KR 20020054685 A KR20020054685 A KR 20020054685A KR 20030035851 A KR20030035851 A KR 20030035851A
Authority
KR
South Korea
Prior art keywords
oil
plant
eugenol
fennel
extract
Prior art date
Application number
KR1020020054685A
Other languages
Korean (ko)
Other versions
KR100387939B1 (en
Inventor
이행병
김순일
박병묵
안용준
Original Assignee
주식회사 내츄로바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 내츄로바이오텍 filed Critical 주식회사 내츄로바이오텍
Priority to KR10-2002-0054685A priority Critical patent/KR100387939B1/en
Publication of KR20030035851A publication Critical patent/KR20030035851A/en
Application granted granted Critical
Publication of KR100387939B1 publication Critical patent/KR100387939B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

PURPOSE: Provided is a fungicide composition containing extracts derived from a plant selected from the group consisting of Foeniculum vulgare, Illicium verum Hook. fil., Asarum Sieboldii Miquel var. seoulens Nakai., Lindera erythrocarpa Makino., etc., which inhibit the growth of pathogenic fungi. CONSTITUTION: A fungicide composition characteristically comprises, as active ingredients, a compound selected from the group consisting of fenchone, eugenol, isoeugenol, methyleugenol, cinnamic alcohol, and cinnamic aldehyde which are extracted from Foeniculum vulgare, Illicium verum Hook. fil., Asarum Sieboldii Miquel var. seoulens Nakai., Lindera erythrocarpa Makino., and Eugenia caryophyllata. It has strong antifungal effects on Trichophyton and candida species, without any adverse effects.

Description

식물 추출물을 포함하는 항균제 조성물{FUNGICIDE COMPOSITION CONTAINING EXTRACTS DERIVED FROM PLANT}Antimicrobial composition comprising plant extract {FUNGICIDE COMPOSITION CONTAINING EXTRACTS DERIVED FROM PLANT}

[발명이 속하는 기술분야][TECHNICAL FIELD OF THE INVENTION]

본 발명은 식물 추출물을 포함하는 항균제 조성물에 관한 것으로서, 더욱 상세하게는 백선균(무좀균)과 칸디다균에 대하여 항균활성을 가지는 회향, 대회향, 세신, 녹나무속 식물 및 정향으로 이루어진 군으로부터 선택된 식물에서 추출한 추출물 또는 화합물을 포함하는 항균제 조성물에 관한 것이다.The present invention relates to an antimicrobial composition comprising a plant extract, and more particularly, extracts from plants selected from the group consisting of fennel, fennel, sessin, camphor and clove having antimicrobial activity against Bacillus aeruginosa (Athletes) and Candida. It relates to an antimicrobial composition comprising an extract or compound.

[종래기술][Private Technology]

진균(곰팡이)에 의해 발생되는 피부질환을 총칭하여 피부진균증(derma-tomycosis)이라 한다. 특히 피부의 각질, 모발, 손톱, 발톱 등의 각질조직에 침입하여 기생하는 피부사상균(dermatophyte)에 의해 발생되는 경우를 피부사상균증(dermato-phytosis), 백선(Tinea) 또는 표재성진균증(superficialfungal infection)이라고 한다.(Ribbon, J. W. (1998) Medical Mycology.InThe pathogenic fungi and the pathogenic actinomyces. 2nd Ed. W.B Saunders Company. Philadelphia, London, Toronto.)Skin diseases caused by fungi (fungus) are collectively called derma-tomycosis. In particular, cases caused by dermatophyte, which invade keratinous tissue such as keratin, hair, nails and toenails of the skin, are called dermato-phytosis, tinea, or superficial fungal infection. and. (Ribbon, JW (1998) Medical Mycology. In The pathogenic fungi and the pathogenic actinomyces. 2nd Ed.. WB Saunders Company. Philadelphia, London, Toronto)

표재성 진균증은 피부 침입부위에 따라 발생부위가 손과 발인 경우 수족족부백선(Tinea manus & Tinea pedis), 얼굴인 경우 안면부백선(Tinea faciale), 두부의 경우에는 두부백선(Tinea capitis), 서혜부(사타구니)에 발생했을 때에는 완선(Tinea cruris), 손톱과 발톱의 경우에 조갑백선(Tinea ungium 또는 Onychomy-cosis), 상기부위를 제외한 부위에 발생한 경우를 체부백선(Tinea corporis)이라고 부른다.(Rezabek, G. H. and Friedman, A. D. 1992.Drugs43(5): 674-682.; Kamalam, A. and Thambiah, A. S. 1976.Sabouraudia14(2): 129-148).Superficial fungal disease occurs in the hands and feet according to the skin invasion area, Tinea manus & Tinea pedis, Tinea faciale in the face, Tinea capitis in the head, and groin (groin). Tinea cruris, tinea ungium or Onychomy-cosis in the case of nails and toenails, and tinea corporis (Tinea corporis) are called cases (Rezabek, GH). and Friedman, AD 1992. Drugs 43 (5): 674-682 .; Kamalam, A. and Thambiah, AS 1976. Sabouraudia 14 (2): 129-148.

표재성 진균증의 주된 원인은 소아포균(microsporum), 표피균(epidermo-phyton), 백색균 (Trichophyton), 칸디다균(candida species), 전풍균(Malassezia furfur)이다. 특히 소아포균(microsporum)은 주로 피부와 체모에 침입하고, 표피균(epider-mophyton)은 피부와 조갑에 침입하며, 백색균 (Trichophyton)은 피부, 체모, 조갑 모두를 침입할 수 있는 특성을 갖고 있다.(Weitzman, I. and Summerbell, R. C. 1995. The dermatophytes. Clinical Microbiology Reviews 8(2): 240-259) 칸디다균은 피부 및 점막에 병변을 일으키고, 전풍균은 반점을 일으키는 전풍(tinea versicolor)의 원인균이 된다.The main causes of superficial mycosis are microsporum, epidermo-phyton, trichophyton, candida species, and Malassezia furfur . In particular, microsporum mainly penetrates the skin and hair, epidermis (epider-mophyton) penetrates the skin and hair, and Trichophyton invades all skin, hair, and hair. (Weitzman, I. and Summerbell, RC 1995. The dermatophytes.Clinical Microbiology Reviews 8 (2): 240-259) Candida bacteria cause lesions on the skin and mucous membranes, and pneumococci cause spots (tinea versicolor). It becomes the causative agent of.

표재성 진균증의 원인균들은 상피세포 상부의 각질조직(keratin)에 기생하여 번식함으로써 표재성 병변을 유발하지만, 때때로 상피 상부이하까지도 염증을 유발할 수도 있고, 백선진(Dermatophytid)을 일으키기도 한다.The causative agents of superficial mycosis are parasitic and multiplying keratin in the upper epithelial cells, causing superficial lesions, but sometimes inferior to the upper epithelium, or dermatophytid.

병원성 곰팡이는 전 세계적인 분포하며, 사람을 포함한 동물에 질병을 유발한다. 병원성 곰팡이는 항상 접촉에 의해 병을 유발시키는 것이 아니고, 감염 곰팡이의 종류, 숙주의 나이, 면역상태, 합병증유무, 피부 건강도, 영양이나 호르몬 상태에 따라 감염여부가 달리 나타난다.(Brasch, J. and Gottkehaskamp, D. 1992. The effect of selected human steroid hormones upon the growth of dermatophytes with different adaptation to man. Mycopathologia 120(2): 87-92)Pathogenic fungi are distributed worldwide and cause disease in animals, including humans. Pathogenic fungi do not always cause disease by contact, but infection depends on the type of fungal infection, the age of the host, the immune status, the presence of complications, the health of the skin, and the nutritional or hormonal status (Brasch, J. and Gottkehaskamp, D. 1992.The effect of selected human steroid hormones upon the growth of dermatophytes with different adaptation to man.Mycopathologia 120 (2): 87-92)

대다수의 더마토파이트 속(Dermatophyte spp)곰팡이에 의한 피부 및 그 부속기 감염을 피부 사상균증(윤선)이라고 한다. 이러한 곰팡이 그룹들은 표피 각화층에 국한되어 서식하며, 일부 종들은 동물 조직 내에 침투하여 서식하기도 한다. 편의상 숙주에 따라, 엔트로필릭(Anthrophillic, 사람기생), 주필릭(Zoophilic, 동물기생), 지오필릭(토양내 기생하는 saprophyte)라 한다.(Gupta, A. K., Einarson, T. R., Summerbell, R. C. and Shear, N. H. 1998. A North American perspective of Drugs. 55(5): 645-674)Infections of the skin and its appendages caused by the majority of the dermatophyte spp fungus are called dermatosis. These fungal groups inhabit only the epidermal keratinous layer, and some species invade and inhabit animal tissues. For convenience, depending on the host, it is referred to as enthrophillic (zoparasitic), zoophilic (zoparasitic), and geophilic (saprophysiological saprophyte) (Gupta, AK, Einarson, TR, Summerbell, RC and Shear). , NH 1998.A North American perspective of Drugs. 55 (5): 645-674)

표재성 진균증의 치료는 원칙적으로 국소 및 전신의 항진균제 사용으로 이루어지며 경우에 따라 각질 용해제의 도포를 병행하여 실시된다. 증상 및 피부병변이 소실된 후에도 약 2-4주간 치료가 요구된다. 그러나, 족부백선의 경우, 환자의 부주의나 신체부위적 특성 및 면역결핍성으로 인하여 치료에 실패하거나 재발할 가능성이 높다.Treatment of superficial mycosis consists in principle of the use of local and systemic antifungal agents, in some cases in parallel with the application of keratolytic agents. Treatment is required for about 2-4 weeks after the disappearance of symptoms and skin lesions. However, tinea ringworm is highly likely to fail or relapse due to carelessness, disposition of the body, and immunodeficiency.

지금까지 많은 항진균제들이 피부진균증을 치료하기 위해 이용되어 왔으나,재발비율이 높고 피부독성에 대한 인식 증가로 인해 보다 안전하고 우수한 항진균물질을 천연물에서 찾으려는 노력이 이루어지고 있다.Until now, many antifungal agents have been used to treat skin fungi, but due to the high recurrence rate and increased awareness of skin toxicity, efforts have been made to find safer and better antifungal substances in natural products.

따라서, 본 발명은 진균에 대하여 항균활성을 가지는 식물 추출물을 제공하는 것을 목적으로 한다.Therefore, an object of the present invention is to provide a plant extract having antibacterial activity against fungi.

또한 본 발명은 백선균 또는 칸디다균에 대하여 항균활성을 가지는 식물 추출물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a plant extract having antibacterial activity against ringworm or Candida.

또한 본 발명은 백선균 또는 칸디다균에 대하여 항균활성을 가지는 식물유래 화합물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a plant-derived compound having antibacterial activity against ringworm or candida.

또한 본 발명은 피부에 안정하며 우수한 항진균성을 가지는 항진균제 조성물을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide an antifungal drug composition that is stable to the skin and has excellent antifungal properties.

도 1은 정향 메탄올 추출물에서 유제놀을 분리하는 과정을 도시한 것이고,1 illustrates a process for separating eugenol from a clove methanol extract,

도 2는 정향유에서 유제놀 및 이소유제놀을 분리하는 과정을 도시한 것이다.2 shows a process for separating eugenol and isoeugenol from clove oil.

상기 목적을 달성하기 위하여 본 발명은 회향, 대회향, 세신, 녹나무속 식물 및 정향으로 이루어진 군으로부터 1종이상 선택된 식물에서 추출한 추출물을 포함하는 항균제 조성물을 제공한다.In order to achieve the above object, the present invention provides an antimicrobial composition comprising an extract extracted from at least one plant selected from the group consisting of fennel, fennel, sessin, camphor and cloves.

또한 본 발명은 펜촌, 유제놀, 이소유제놀, 메틸유제놀, 신나밀알콜 및 신남알데하이드로 이루어진 군으로부터 1종 이상 선택된 화합물을 포함하는 항균제 조성물을 제공한다.The present invention also provides an antimicrobial composition comprising at least one compound selected from the group consisting of phenchon, eugenol, isoeugenol, methyl eugenol, cinnamil alcohol and cinnanamaldehyde.

이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

본 발명자들은 회향, 세신, 녹나무속 식물 및 정향이 항진균 활성을 가짐을확인하고 본 발명을 완성하였다.The inventors have confirmed that fennel, sessin, camphor and clove have antifungal activity and have completed the present invention.

회향(Foeniculum vulgare)은 대회향, 일명 팔각회향(Illicium verum)과 주요성분들이 거의 동일한 것으로 알려져 있다.(김창민, 신민교, 안덕균, 이경순 등. 1998. 중약대사전, vol. 9, 정담출판사, 5813-5816; vol. 10, 6597-6603.)Fennel ( Foeniculum vulgare ) is known to be almost the same as the main components of the scented thyme, also known as octagonal fennel ( Illicium verum ) (Kim Chang-min, Shin Mingyo, Ahn Deok-kyun, Lee Kyung-soon, etc. 1998. Chinese Medicine Dictionary, vol. ; vol. 10, 6597-6603.)

녹나무속 식물로는 육계(Cinnamomum sieboldii), 계피(C. cassia), 실론육계(C. zeylanica), 계수나무 및 육계나무(C. laureirii)가 있다. 한방에서는 녹나무과의 식물의 박피(뿌리, 줄기, 가지) 중 두껍게 껍질을 벗겨 건조시킨 것을 육계, 그 보다 작은 가지의 껍질을 벗겨 건조한 것을 계피, 그리고 아주 가느다란 가지의 껍질을 건조시킨 것을 계지라고 한다. 또한 녹나무과의 녹나무속(Cinnamomum)의 수피를 벗겨서 건조시킨 것을 계피 또는 육계라 칭한다.Camphor plants include Cinnamomum sieboldii , Cinnamon C. cassia , C. zeylanica , Cassia and C. laureirii . In Chinese medicine, the peeled and dried bark of the camphor plant (root, stem, and eggplant) is dried, and the bark of smaller branches is dried, cinnamon, and the very thin eggplant is dried. . Also, peeled and dried bark of the Camphor tree of Cinnamomum ( Cinnamomum ) is called cinnamon or broiler.

상기 정향은 유제니아 카리오필라타(Eugenia caryophyllata) 또는 시지기움 마로마티컴(Syzygium aromaticum)으로, 상기 식물체의 정유는 정향유로 상용화되고 있으며, 특히 클로브 버드 오일(clove bud oil)은 정향의 꽃봉오리만을 채집하여 얻은 식물체 정유이다.The clove is Eugenia caryophyllata or Syzygium aromaticum , the essential oil of the plant is commercialized as clove oil, in particular, clove bud oil (clove bud oil) only collect the buds of the clove Plant essential oil obtained by.

본 발명의 식물들은 통상의 추출방법으로, 바람직하게는 식물 분쇄물을 증류수, 알콜 또는 유기용매에 혼합하고, 분획한 다음 용매를 건조시켜 식물 추출물을 제조한다. 알콜은 탄소수 1 내지 5가 바람직하며, 더욱 바람직하게는 에탄올, 메탄올, 프로판올 또는 부탄올이며, 가장 바람직하게는 메탄올이다. 유기용매는 헥산, 클로로포름 또는 에틸아세테이트가 바람직하며, 가장 바람직하게는 헥산이다. 추출부위는 식물의 꽃, 엽, 줄기, 꽃봉우리, 뿌리, 수지, 열매, 종자, 식물체 등에서 추출되며, 회향 추출물은 회향열매 추출물이 바람직하고, 세신 추출물은 세신 뿌리 추출물이 바람직하고, 녹나무속 추출물 및 정향 추출물은 뿌리 추출물이 바람직하다. 그러나, 상기에 기재한 바람직한 추출부위에 한정되는 것은 아니다.The plants of the present invention are prepared by a conventional extraction method, preferably by mixing plant comminutes with distilled water, alcohol or an organic solvent, fractionating and drying the solvent. The alcohol preferably has 1 to 5 carbon atoms, more preferably ethanol, methanol, propanol or butanol, and most preferably methanol. The organic solvent is preferably hexane, chloroform or ethyl acetate, most preferably hexane. Extraction part is extracted from the flowers, leaves, stems, buds, roots, resins, fruits, seeds, plants of plants, etc.Fennel extract is preferably fennel extract, Sessin extract is preferably Sessin root extract, Camphor extract And clove extract is preferably a root extract. However, it is not limited to the preferable extraction site described above.

또한 본 발명의 식물들은 정유로 제조할 수 있다. 식물 정유는 통상의 정유 추출법으로 추출하거나, 시판되는 정유를 구입하여 사용할 수 있다. 대표적인 추출법은 물이나 수증기를 이용한 증류법과 압착법이 있다. 시판되는 정유에는 펜낼 스위트 오일(회향유), 신나먼 오일(계피유) 및 클로브 버드 오일(정향유)이 있다.The plants of the present invention can also be prepared with essential oils. Plant essential oils can be extracted by a conventional essential oil extraction method, or a commercial oil can be purchased and used. Representative extraction methods include distillation using water or steam and compression. Commercial essential oils include Pennyl Sweet Oil (Fennel Oil), Cinnamon Oil (Cinnamon Oil), and Clove Bud Oil (Clove Oil).

본 발명의 식물 추출물 또는 정유는 무좀을 유발하는 백선균 및 칸디다균에 적용하여 생육 저해환(Clear zone)을 측정한 결과 모두 우수한 항진균 활성을 나타내었으며, 그중 세신 추출물, 정향 추출물, 계피유 및 정향유가 보다 높은 항진균 활성을 나타내었다.The plant extract or essential oil of the present invention showed excellent antifungal activity as a result of measuring the clear zone by applying to the fungus-induced ringworm and Candida fungi, among which the sericin extract, cloves extract, cinnamon oil and cloves oil were better. It showed high antifungal activity.

또한 본 발명은 식물유래 항진균성 화합물을 제공한다. 항진균성 화합물은 정향 유래 화합물인 유제놀 및 이소유제놀, 회향 유래 화합물인 펜촌, 육계 유래 화합물인 신나밀알콜 및 신남 알데하이드, 및 메틸유제놀을 포함한다. 상기 항진균성 화합물은 시판되는 화합물을 구입하여 사용할 수 있으며, 상기 식물로부터 공지된 기술로 분리, 정제할 수 있다.The present invention also provides plant-derived antifungal compounds. Antifungal compounds include eugenol and isoeugenol, which are clove-derived compounds, fenchon, which is a fennel-derived compound, cinnamil alcohol and cinnamic aldehyde, which are broiler-derived compounds, and methyl eugenol. The antifungal compound may be purchased by using a commercially available compound, and may be separated and purified from the plant by a known technique.

본 발명은 식물 추출물 또는 항진균성 화합물을 포함하는 항균제 조성물을 제공한다. 상기 항균제 조성물은 병원성 곰팡이에 대하여 생육억제 활성을 가지는 것으로, 바람직하게는 백선균 또는 칸디다균에 대하여 생육 저해 활성을 갖는다.The present invention provides an antimicrobial composition comprising a plant extract or an antifungal compound. The antimicrobial composition has growth inhibitory activity against pathogenic fungi, and preferably has growth inhibitory activity against ringworm or candida.

본 발명의 항진균제 조성물은 하기 표 1로 기재한 병원성 곰팡이에 대하여항균효과를 가진다. 대표적인 병원성 곰팡이는 트리코피톤 루프럼(Trichophyton rubrum, KCTC 6345), 미코스포럼 오더이니(Micosporum audouinii, KCTC 6346), 트리코피톤 페러기네움(Trichophyton ferrugineum, KCTC6351), 에피더모피톤 플로코섬(Epidermophyton floccosum, KCTC 6586), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes, KCTC 6077) 및 칸디다 알비칸스(Candida albicans, KCTC 6586)이다.The antifungal composition of the present invention has an antifungal effect against the pathogenic fungus described in Table 1 below. Representative pathogenic fungi include Trichophyton rubrum (KCTC 6345), Micosporum audouinii (KCTC 6346), Trichophyton ferrugineum (KCTC6351), Epidermophyton floccosum a KCTC 6586), tricot piton menta thereof blood test (Trichophyton mentagrophytes, KCTC 6077) and Candida albicans (Candida albicans, KCTC 6586).

진균류 (곰팡이균종명)Fungi (Mold Fungus) 생태ecology 털에 침입Breaking into the fur 발병부위Onset 소포자균속(Microsporum sp.) Microsporum sp. M.M. audouiniiaudouinii 인간친화성Human friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) 두부tofu M. canisM. canis 동물친화성Animal friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) 두부, 독창, 두발, 안면, 체부Tofu, solo, hair, face, body M. gypseumM. gypseum 토양친화성Soil-friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) 두부tofu M. fulvumM. fulvum 토양친화성Soil-friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) M. cookeiM. cookei 토양친화성Soil-friendly M. distortumM. distortum 동물친화성Animal friendly 표피균속(Epidermophyton sp.) Epidermophyton sp. E. floccosumE. floccosum 인간친화성Human friendly 완선, 족부, 조갑Complete, feet, armor 백선균속(Trichophyton sp.) Trichophyton sp. T. rubrumT. rubrum 인간친화성Human friendly 수발, 안면, 체부, 완선, 족부, 조갑Veterinary, Facial, Body, Complete, Foot, Armor T. mentagrophytesT. mentagrophytes 동물친화성Animal friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) 두부,독창,두발,안면,체부,완선,족부,조갑Tofu, originality, hair, face, body, complete, foot, armor T. ferrugineumT. ferrugineum 인간친화성Human friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) 두부, 체부Tofu, body T. violaceumT. violaceum 인간친화성Human friendly 모내균(모발내부기생)Inner Hair (Internal Hair Parasitic) 두부, 조갑Tofu, armor T. verrucosumT. verrucosum 동물친화성Animal friendly 모외균(모발외부기생)Hair follicle (hair external parasitic) 두부, 두발Tofu, hair T. tonsuransT. tonsurans 인간친화성Human friendly 모내균(모발내부기생)Inner Hair (Internal Hair Parasitic) 두부tofu T. schoenleiniiT. schoenleinii 인간친화성Human friendly 모내균(모발내부기생)Inner Hair (Internal Hair Parasitic) 두부, 황선Tofu, yellow wire T. simiiT. simii 동물친화성Animal friendly 모내균(모발내부기생)Inner Hair (Internal Hair Parasitic) 두부tofu T. terrestreT. terrestre 토양친화성Soil-friendly T. gallinaseT. gallinase 동물친화성Animal friendly T. megniniiT. megninii 인간친화성Human friendly

본 발명의 항진균제 조성물은 병원성 곰팡이의 생육억제를 위한 용도로 사용할 수 있으며, 바람직하기로는 세정제, 무좀 등의 피부진균증(derma-tomycosis) 치료제, 소독제 등으로 사용될 수 있다.The antifungal composition of the present invention can be used for the purpose of inhibiting the growth of pathogenic fungi, and preferably, it can be used as an agent for treating derma-tomycosis such as athlete's foot, athlete's foot, and disinfectant.

항진균제 조성물의 제제(製劑)는 경고제(硬膏劑), 과립제(顆粒劑), 로션제(lotiones) , 리니멘트제(liniments), 리모나데제(limonades), 방향수제(芳香水劑), 산제(散劑), 시럽제(syrups), 안연고제(眼軟膏劑), 액제(液劑), 에어로솔제(aerosols), 엑스제(extracts), 엘릭실제(elixier), 연고제(軟膏劑), 유동(流動)엑스제, 유제, 현탁제, 침제(浸劑), 전제(煎劑),점안제(點眼劑), 정제(錠劑), 좌제(坐劑), 주사제, 주정제(酒精劑), 카타플라스마제(cataplasma), 캡슐제(capsules), 크림제, 트로키제(troches), 틴크제(tincture), 파스타제(pasta) 또는 환제(丸劑)가 바람직하나, 상기 제제에 한정되지 않는다.Formulations of antifungal composition include warning agents, granules, lotions, liniments, limonades, fragrances and powders. Syrups, ophthalmic ointments, liquids, aerosols, extracts, elixiers, ointments, fluids X), emulsion, suspension, acupuncture, premise, eye drops, tablets, suppositories, injectables, spirits, kata Plasma, capsules, cream, troches, tincture, pasta or pills are preferred, but not limited to the above formulations.

항진균제 조성물은 제제 및 사용방법에 따라 생리약학적으로 허용가능한 담체를 더욱 포함할 수 있으며, 항진균제 조성물 내 식물 추출물 또는 정유의 함량은 1 내지 20 중량 %가 바람직하다. 항진균제 조성물의 투여량은 1일 10 내지 50 mg으로 1회 내지 3회 실시하는 것이 바람직하나, 병의 중한 정도 및 환자의 건강상태에 따라 조절하는 것이 더욱 바람직하다.The antifungal composition may further include a physiologically acceptable carrier according to the formulation and the method of use, and the content of the plant extract or the essential oil in the antifungal composition is preferably 1 to 20% by weight. The dose of the antifungal agent is preferably administered once to three times at 10 to 50 mg per day, but more preferably adjusted according to the severity of the disease and the health of the patient.

이하 본 발명의 실시예를 기재한다. 하기 실시예는 본 발명을 예시하기 위한 것일 뿐 본 발명이 하기 실시예에 한정되는 것은 아니다.Hereinafter, examples of the present invention will be described. The following examples are only for illustrating the present invention and the present invention is not limited to the following examples.

실시예 1: 항균성 식물 추출물 제조Example 1 Preparation of Antimicrobial Plant Extracts

회향(Foeniculum vulgare)의 열매, 세신(Asarum heterotropoides)의 뿌리, 육계(Cinnamomum sieboldii) 또는 정향(Eugenia caryophyllata)의 꽃봉오리, 계피를 구입하였고, 각각에 대하여 메탄올 추출물을 수득하였다. 메탄올 추출물 제조방법은 모두 동일하게 실시하였고, 일예로 회향의 열매 메탄올 추출방법을 나타내었다.Fruits of fennel ( Foeniculum vulgare ), roots of Asarum heterotropoides , buds of broiler ( Cinnamomum sieboldii ) or cloves ( Eugenia caryophyllata ) and cinnamon were purchased and methanol extracts were obtained for each. Methanol extract manufacturing method was carried out in the same manner, as an example showed a fruit methanol extraction method of fennel.

회향(Foeniculum vulgare) 열매 300 g을 믹서기로 곱게 마쇄하고, 500 ml 삼각플라스크에 넣은 다음 메탄올 200 ml을 혼합하여 실온 암실에서 2일간 방치하였다. 2일 후 감압여과하여 얻은 여과액을 회전진공농축기(EYELA autojack NAJ-160, Japan)로 농축하였다. 여과지에 걸러진 마쇄물은 다시 메탄올에 혼합하는 과정을 거쳐 최종적으로 메탄올 추출물을 제조하였다.300 g of Foeniculum vulgare fruit was ground finely in a blender, placed in a 500 ml Erlenmeyer flask, mixed with 200 ml of methanol, and left in a dark room at room temperature for 2 days. After 2 days, the filtrate obtained by filtration under reduced pressure was concentrated using a rotary vacuum concentrator (EYELA autojack NAJ-160, Japan). The filtered material filtered through the filter paper was again mixed with methanol to finally prepare a methanol extract.

실시예 2: 항균성 식물 정유의 제조Example 2: Preparation of Antimicrobial Plant Essential Oils

진아향료(주) 회향유, 육계유, 계피유, 정향유를 구입하였다.Jinhyang Co., Ltd. Fennel oil, broiler oil, cinnamon oil, clove oil were purchased.

상기 정유는 증류법(steam distillation)으로 제조한 것이다. 소량의 증류수와 회향, 육계 및 정향 각각을 믹서로 곱게 마쇄하여 3 L 농축플라스크에 넣었다. 가열멘틀(heating mentle)상에서 상기 플라스크의 멘틀 온도를 약 70 ℃로 하고, 디에틸에테르(diethyl ether)와 헥산이 각각 40 ml(1/1, v/v)씩 담긴 플라스크의 멘틀 온도를 30∼40 ℃(약 38℃)로 하여 2시간 동안 가열하였다. 한번 증류하는데 필요한 시료의 양은 250 g로 하고 추출 후 추출물 내에 함유된 수분을 제거하기 위해 무수황산나트륨(Na2SO4)을 소량 넣은 다음 데시케이터(desiccator)에 방치하였고 이후 여지(Toyo No. 2)에 걸러 농축하였다.The essential oil is prepared by steam distillation. A small amount of distilled water, fennel, broiler, and clove were each finely ground in a mixer and placed in a 3 L concentrated flask. The flask's mantle temperature is about 70 ° C. on a heating mentle, and the flask's mantle temperature is 30 to 40 ml (1/1, v / v) containing diethyl ether and hexane, respectively. It heated at 40 degreeC (about 38 degreeC) for 2 hours. The amount of sample required for distillation once was 250 g, and after extraction, a small amount of anhydrous sodium sulfate (Na 2 SO 4 ) was added to remove moisture contained in the extract, and then left in a desiccator. ), And concentrated.

실시예 3: 곰팡이의 생육저해활성 측정Example 3 Measurement of Growth Inhibition Activity of Mold

한국 유전자은행(Korean Collection for Type Cultures, KCTC)으로부터 트리코피톤 루프럼(Trichophyton rubrum, KCTC 6345), 미코스포럼 오더이니(Micosporumaudouinii, KCTC 6346), 트리코피톤 페러기네움(Trichophyton ferrugineum, KCTC6351), 에피더모피톤 플로코섬(Epidermophyton floccosum, KCTC 6586), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes, KCTC 6077), 칸디다 알비칸스(Candida albicans, KCTC 6586) 6종을 분양받았다. 곰팡이 생육저해활성은 여지확산법(Paper disc diffusion method)으로 검정하였다. Trichophyton rubrum (KCTC 6345), Micosporumaudouinii (KCTC 6346), Trichophyton ferrugineum (KCTC6351), Epik from Korean Collection for Type Cultures (KCTC) the fur t flow koseom (Epidermophyton floccosum, KCTC 6586), tricot piton menta him blood test (Trichophyton mentagrophytes, KCTC 6077), Candida albicans (Candida albicans, KCTC 6586) was pre-sale 6 species. Inhibitory activity of fungi was assayed by the paper disc diffusion method.

분양받은 균주를 사보라우드 한천(Sabouraud's agar) 배지에 접종한 후 각 메탄올 추출물(실시예 1)을 메탄올에 녹이거나 정유(실시예 2) 자체를 직접 여지(paper disc)에 처리하였다. 여지를 각 균이 접종된 상기 배지에 올려놓고 28 ℃에서 5일간 호기배양 한 후, 여지 주위에 형성된 생육저해환(clear zone)의 크기를 보고 항균활성을 확인하였다.After the inoculated strains were inoculated in Sabouraud's agar medium, each methanol extract (Example 1) was dissolved in methanol, or the essential oil (Example 2) was treated directly on a paper disc. After cultivation in the medium was inoculated with each strain and incubated at 28 ℃ for 5 days, the antibacterial activity was confirmed by looking at the size of the growth zone (clear zone) formed around the margin.

하기 표 2는 메탄올 추출물과 정유에 대한 여지당 적정농도를 처리하였을 때, 백선균 5종과 칸디다균 1종에 대해 보이는 생육저해활성을 측정하여 나타낸 것이다.Table 2 below shows the measured inhibitory activity against virulent Bacillus spp. And Candida spp. When treated with methanol extract and the optimal concentration per room for essential oil.

저해환, mmInhibitory ring, mm 처리농도, mg/여지Treatment concentration, mg / filter 회향fennel 회향유Fennel oil 세신Sesin 육계Broiler 육계유Broiler oil 정향cloves 정향유Clove oil 계피cinnamon 계피유Cinnamon milk 5050 100100 5050 1010 2020 1010 1010 5050 1010 1010 5050 2525 1010 5050 2525 1010 미코스포럼 오더이니I'm ordering the Micos Forum. 1111 1414 1313 88 1616 1616 2828 2525 3030 2525 4545 4444 2828 >50> 50 >50> 50 >50> 50 트리코피톤 페러기네움Trichophyton Peregrineum 1010 1717 1111 99 1515 1515 2727 2424 2828 2626 4444 4040 2727 >50> 50 >50> 50 >50> 50 칸디다 알비칸스Candida albicans 99 1414 1111 99 2020 1616 3737 2626 3030 2424 4848 4545 3737 >50> 50 >50> 50 >50> 50 트리코피톤 멘타그로피테스Trichophyton Mentagrophytes 99 1414 1010 88 1717 1616 3535 2626 3030 2222 4545 4444 3535 >50> 50 >50> 50 >50> 50 에피더모피톤 플로코섬Epidermophyton Floco Island 1010 1515 1010 99 1818 1515 3030 2525 2222 2525 4949 4242 3030 4545 4444 4242 트리코피톤 루프럼Trichophyton Lurum 1212 1414 1010 99 1616 1515 2828 2323 2424 2020 4848 4141 2828 4848 4545 4444

메탄올 추출물 또는 정유에 의한 생육저해환의 크기가 10 mm 이상으로 나타난 경우 곰팡이 생육저해활성을 가지는 것으로 판단하였다. 상기 표 2에 제시된 바와 같이, 미코스포럼 오디이니에 대해 회향 메탄올 추출물 50 mg 처리시 항균활성을 나타내었고, 회향유는 여지당 100 mg과 50 mg 처리시 항균활성을 나타내었으며, 세신은 10 mg 이상 처리시 항균활성을 보였다. 또한 육계 메탄올 추출물 및 육계유는 각각 10 mg과 50 mg 처리시 아주 강한 생육 저해환을 형성하였고, 정향 메탄올 추출물 및 정향유 역시 10 mg 처리시 매우 넓은 저해환을 형성하였다. 이러한 항균활성은 나머지 진균들에서도 비슷한 양상을 보였다.When the size of the growth inhibition ring by methanol extract or essential oil was 10 mm or more, it was determined to have fungal growth inhibition activity. As shown in Table 2, the antimicrobial activity of 50 mg of fennel methanol extract showed an antimicrobial activity for the medicinal extract of fennel methanol, and the fennel oil exhibited the antimicrobial activity of 100 mg and 50 mg per litter, and the sessin was more than 10 mg. When treated, it showed antimicrobial activity. In addition, broiler methanol extract and broiler oil formed very strong growth inhibitory rings when treated with 10 mg and 50 mg, respectively. Clove methanol extract and clove oil also formed very broad inhibitory rings when treated with 10 mg. This antimicrobial activity was similar in the other fungi.

실시예 4: 항진균성 화합물의 분리Example 4: Isolation of Antifungal Compounds

(1) 유제놀 분리(1) Eugenol Separation

정향 메탄올 추출물(20 g)을 헥산(800 ml), 클로로포름(800 ml), 에틸아세테이트(800 ml), 물층으로 분획하여 헥산 12.6 g, 클로로포름 3.8 g, 에틸아세테이트0.8 g 및 물층 2.4 g을 수득하였다. 각 분획에 대한 항균활성을 검정하였고, 헥산 분획이 항균활성을 나타냄을 확인하였다.Clove methanol extract (20 g) was partitioned into hexane (800 ml), chloroform (800 ml), ethyl acetate (800 ml) and water layer to give 12.6 g of hexane, 3.8 g of chloroform, 0.8 g of ethyl acetate and 2.4 g of water layer. . The antimicrobial activity of each fraction was assayed and the hexane fraction was confirmed to exhibit antimicrobial activity.

헥산 분획 12.6 g을 실리카겔칼럼(Merck 230 mesh, 600g, 직경 5.5 x 70 cm)으로 색층분석하고, 헥산-에틸아세테이트로 순차분획(stepwise gradient, 헥산: 에틸아세테이트(5:1 ->3:1, v/v))하여 용출물들을 수득하였다. 용출물들은 TLC(Thin layer chromatography)을 실시하여 동일한 스팟으로 확인되면 합쳐서 농축하여 H1(1.4 g), H2(27. g), H3(0.4 g), H4(0.2 g)로 분리하였다. 각 분획들에 대한 항균활성을 검정한 결과 H1과 H2가 항균활성을 나타내었다. 이후 H2가 H1에 비하여 많은 수득율을 보여, H2를 대상으로 항균활성 물질을 분리하였다.12.6 g of the hexane fraction was chromatographed on a silica gel column (Merck 230 mesh, 600 g, 5.5 x 70 cm in diameter) and stepwise gradient (hexane: ethyl acetate (5: 1-> 3: 1, v / v)) to eluate. The eluates were separated by concentration of H1 (1.4 g), H2 (27. g), H3 (0.4 g), and H4 (0.2 g) by TLC (Thin layer chromatography). As a result of assaying the antimicrobial activity of each fraction, H1 and H2 showed antimicrobial activity. Since H2 shows a much higher yield than H1, the antimicrobial active material was separated from H2.

H2는 고속액체크로마토그라피(Spectra System P2000)를 실시하였다. 칼럼(μPorasil, 내경 19 mm x 길이 300 mm)에 분당 3 ml의 속도로 헥산:에틸아세테이트 (9:1, v/v) 용매를 흘려주었고, 용출물은 242 nm에서 검출하여 화합물 I을 수득하였다. 화합물 I은 EI-MS,1H와13C-NMR 등의 분광분석에 기초하여 분석한 결과 화학식 1의 유제놀(eugenol)로 동정되었다.H2 was subjected to high performance liquid chromatography (Spectra System P2000). Hexane: ethyl acetate (9: 1, v / v) solvent was flowed into the column (μPorasil, inner diameter 19 mm x length 300 mm) at a rate of 3 ml per minute, and the eluate was detected at 242 nm to obtain compound I. . Compound I was identified as eugenol of Formula 1 by analysis based on spectroscopic analysis such as EI-MS, 1 H and 13 C-NMR.

[화학식 1][Formula 1]

(2) 정향유에서 이소유제놀과 유제놀의 분리(2) Separation of isoeugenol and eugenol from clove oil

정향유 1 mg에서 이소유제놀과 유제놀을 분리하였다.(도 2)Isoeugenol and eugenol were separated from 1 mg of clove oil (FIG. 2).

정향유를 분석용 고속액체크로마토그라피(analytical HPLC, μPorasil:직경 10 ㎛, 내경 3.9 mm x 길이 300 mm)에서 분당 2 ml, 흡광도 242nm, 용매조건 헥산:에틸아세테이트 9:1(v/v)에서 이소유제놀과 유제놀을 분리하였다. 동일한 조건하에서 분취용 칼럼(μPorasil, 레진직경 10 ㎛, 내경 19 mm x 길이 300 mm) 사용하여 화합물 H1, H2, H3을 정제하였다. 3종의 화합물(H1, H2, H3)에 대한 항균활성을 검정하였고, 항균활성 화합물 H2와 H3을 확인하였다.Clove oil is analyzed by high-performance liquid chromatography (analytical HPLC, μPorasil: 10 μm in diameter, 3.9 mm in diameter x 300 mm in length), 2 ml per minute, absorbance 242 nm, solvent condition hexane: ethyl acetate 9: 1 (v / v). Eugenol and eugenol were separated. Under the same conditions, compounds H1, H2, H3 were purified using a preparative column (μPorasil, resin diameter 10 μm, internal diameter 19 mm x length 300 mm). The antimicrobial activity of three compounds (H1, H2, H3) was assayed, and the antimicrobial active compounds H2 and H3 were identified.

시그마(Sigma)에서 이소유제놀과 유제놀을 구입하였고, 이소유제놀과 유제놀의 표준품과 EI-MS을 H2 및 H3과 비교하였다. 그 결과 H2는 유제놀로 동정되었고, H3은 이소유제놀로 동정되었다. 이소유제놀은 화학식 2로 표현된다.Isoeugenol and eugenol were purchased from Sigma, and the standards of isoeugenol and eugenol and EI-MS were compared with H2 and H3. As a result, H2 was identified as eugenol and H3 was identified as isoeugenol. Isoeugenol is represented by the formula (2).

[화학식 2][Formula 2]

실시예 5: 화합물의 항진균성 검정Example 5: Antifungal Assay of Compounds

유제놀, 이소유제놀에 대한 항진균 활성을 검정하였고, 그 외 회향유 유래 펜촌 및 육계 유래 신나밀알콜과 신남알데하이드의 항진균 활성을 동일하게 검정하였다.The antifungal activity of eugenol and isoeugenol was assayed, and the antifungal activity of cinnamon-derived fenchon-derived broiler-derived cinnamic alcohol and cinnamic aldehyde was also tested.

생육 저해환의 크기, mmGrowth inhibition ring size, mm 처리농도, mg/여지Treatment concentration, mg / filter 펜촌Penchon 유제놀Eugenol 이소유제놀Isoeugenol 신나밀알콜Cinnamic Alcohol 신남알데하이드Cinnamic aldehyde 메틸유제놀Methyl Eugenol 클로트리마졸Clotrimazole 5050 1010 1010 1010 1010 1010 55 2.52.5 1.251.25 55 2.52.5 1.251.25 미코스포럼 오더이니I'm ordering the Micos Forum. 1616 99 3131 2525 2828 4848 3232 3030 1515 3535 2323 2121 트리코피톤 페러기네움Trichophyton Peregrineum 1212 1111 3131 2525 2828 3838 2525 2626 1515 3333 3030 2323 칸디다 알비칸Candida Albican 1313 1010 3030 2424 2828 4444 2525 2323 1313 2525 2222 2222 트리코피톤 멘타그로피테스Trichophyton Mentagrophytes 1515 99 2828 2323 2727 4040 2323 2525 1414 3636 1818 1919 에피더모피톤 플로코섬Epidermophyton Floco Island 1414 99 2525 2424 2525 3535 3030 2828 1414 2727 2424 1818 트리코피톤 루프럼Trichophyton Lurum 1313 1010 2626 2222 2929 4040 3131 2727 1616 2828 2323 1818

상기 표 3에서, 클로트리미졸은 양성대조군이다. 미코스포럼 오더이니에 대하여 펜촌은 여지당 50 mg 처리시 강한 저해활성을 나타내었고, 유제놀과 이소유제놀은 10 mg 처리시 매우 강한 저해활성을 나타내었으며, 신나밀알콜은 전체적으로 25 mm 이상에서 강한 저해활성을 나타내었다. 신남알데하이드, 메틸유제놀은 가장 강한 항진균 활성을 나타내었다. 각 화합물들의 저해활성환의 크기는 처리 농도 및 균주에 따라 약간의 차이를 보이지만, 전체적인 생육저해활성에 있어서는 비슷한 양상을 보였다.In Table 3, clotrimizol is a positive control. Pencoin showed strong inhibitory activity at 50 mg treatment, Eugenol and Isoeugenol showed very strong inhibitory activity at 10 mg treatment. It showed strong inhibitory activity. Cinnamic aldehyde and methyl eugenol showed the strongest antifungal activity. The size of the inhibitory ring of each compound was slightly different depending on the treatment concentration and strain, but showed similar pattern in overall growth inhibition activity.

실시예 6: 임상실험Example 6: Clinical Trials

(1) 회향유에 대한 임상실험(1) Clinical trial on fennel oil

회향유를 에탄올에 녹여 5 %로 회향유 조성물을 제조한 다음 무좀균에 의해 족부가 감염된 5명의 성인 남성을 대상으로 임상실험을 하였다.Fennel oil was dissolved in ethanol to prepare a fennel oil composition at 5%, and then clinical trials were conducted in five adult men infected with foot fungus by athlete's foot.

회향유 조성물은 매일 3초 동안 1회 발에 분무하여(회향유 성분이 0.15 g 처리된 수준) 무좀균의 진전경과를 시간별로 조사하였다.The fennel oil composition was sprayed into the foot once every three seconds (at a level of 0.15 g of the fennel oil component) to investigate the progress of athlete's foot over time.

무좀이 심한 사람의 경우 사용시간에 따라 하기의 양상이 나타났다.For athletes with severe athlete's foot, the following pattern appeared according to usage time.

(1) 처리 1일: 갈라지고 습진과 같이 진눌린 상피세포 또는 조직에서 나오는 진물이 사라졌다.(1) Treatment Day 1: The oozing from the epithelial cells or tissues cracked and crushed like eczema disappeared.

(2) 처리 2일: 갈라진 부위가 서서히 아물었다.(2) Day 2 of treatment: The cracked site gradually healed.

(3) 처리 3일: 무좀 부위의 각질이 형성되고, 무좀 부위에서의 통증이 사라졌다.(3) Day 3 of treatment: keratin was formed at the athlete's foot, and pain at the athlete's foot disappeared.

(4) 처리 4일: 각질의 형성이 매우 두드러져 완전히 치유된 양상을 보였다.(4) Day 4 treatment: The formation of keratin was very prominent, showing complete healing.

무좀이 심하지 않은 사람의 경우 1일 2회 처리로도 충분한 각질형성을 유도하여 무좀의 완치가 가능하였다.In case of athlete's foot, it was possible to cure athlete's foot by inducing enough keratin formation even twice a day.

또한 회향유의 도포하는 기간 중에 환자의 피부에 별다른 병반 및 부작용이 관찰되지 않았다.In addition, no lesions and side effects were observed on the skin of the patient during the application of the fennel oil.

따라서, 회향유 조성물은 무좀이 형성된 조직의 각질화를 야기시켜 백선균의 생육조건의 변화를 가져오며, 무좀을 치료한다.Therefore, the fennel oil composition causes keratinization of the athlete's foot-forming tissues, thereby bringing about changes in the growth conditions of ringworm, and treating athlete's foot.

본 발명은 회향, 대회향, 세신, 녹나무속 식물 및 정향에서 항균성 추출물을 분리하였고, 항균성 화합물 펜촌, 유제놀, 이소유제놀, 메틸유제놀, 신나밀알콜 및 신남알데하이드를 동정하였다. 상기 항균성 추출물 및 항균성 화합물은 백선균과 칸디다균에 대해 매우 강한 항균활성을 가지므로 독성이 없는 천연항균제로서 이용가능성이 매우 높다.The present invention isolated antibacterial extracts from fennel, fennel, sessin, camphor and clove, and identified the antimicrobial compounds Fenchon, Eugenol, Isoeugenol, Methyl Eugenol, Cinnamil Alcohol and Cinnanamaldehyde. Since the antimicrobial extract and the antimicrobial compound have very strong antimicrobial activity against ringworm and Candida, it is highly applicable as a natural antimicrobial agent without toxicity.

Claims (3)

펜촌, 유제놀, 이소유제놀, 메틸유제놀, 신나밀알콜 및 신남알데하이드로 이루어진 군으로부터 선택된 화합물을 포함하는 항균제 조성물.An antimicrobial composition comprising a compound selected from the group consisting of phenchon, eugenol, isoeugenol, methyl eugenol, cinnamil alcohol and cinnanamaldehyde. 제 1항에 있어서, 상기 항균제 조성물은 백선균 및 칸디다균에 대해 항균활성을 갖는 것인 항균제 조성물.The antimicrobial composition of claim 1, wherein the antimicrobial composition has antimicrobial activity against ringworm and Candida. 제 1항에 있어서, 상기 항균제 조성물은 무좀을 치료하는 용도로 사용되는 것인 항균제 조성물.The antimicrobial composition of claim 1 wherein the antimicrobial composition is used for treating athlete's foot.
KR10-2002-0054685A 2002-09-10 2002-09-10 Fungicide composition containing extracts derived from plant KR100387939B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2002-0054685A KR100387939B1 (en) 2002-09-10 2002-09-10 Fungicide composition containing extracts derived from plant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0054685A KR100387939B1 (en) 2002-09-10 2002-09-10 Fungicide composition containing extracts derived from plant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020020003839A Division KR100371858B1 (en) 2001-10-24 2002-01-23 Antimicrobial composition containing plant extract

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR10-2003-0005510A Division KR100437576B1 (en) 2003-01-28 2003-01-28 Fungicide composition containing cinnamylalcohol
KR10-2003-0005509A Division KR100427584B1 (en) 2003-01-28 2003-01-28 Fungicide composition containing extracts derived from plant

Publications (2)

Publication Number Publication Date
KR20030035851A true KR20030035851A (en) 2003-05-09
KR100387939B1 KR100387939B1 (en) 2003-06-27

Family

ID=29578288

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0054685A KR100387939B1 (en) 2002-09-10 2002-09-10 Fungicide composition containing extracts derived from plant

Country Status (1)

Country Link
KR (1) KR100387939B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100769669B1 (en) * 2005-09-15 2007-10-23 충남대학교산학협력단 A Composition comprising methyl eugenol for control of Botrytis cinerea
WO2010027221A2 (en) * 2008-09-04 2010-03-11 재단법인 제주하이테크산업진흥원 Skin-whitening composition comprising an extract, fraction or compound derived from lindera erythrocarpa
KR20240019987A (en) 2022-08-05 2024-02-14 동의대학교 산학협력단 Antibacterial composition containing field aster extract and antibacterial or deodorizing composition containing same
KR20240020237A (en) 2022-08-05 2024-02-14 동의대학교 산학협력단 Composition for antibacterial and anti-inflammatory comprising extract of coastal hogfennel, and composition for preventing or improving asthma, eczema and rhinitis comprising the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100769669B1 (en) * 2005-09-15 2007-10-23 충남대학교산학협력단 A Composition comprising methyl eugenol for control of Botrytis cinerea
WO2010027221A2 (en) * 2008-09-04 2010-03-11 재단법인 제주하이테크산업진흥원 Skin-whitening composition comprising an extract, fraction or compound derived from lindera erythrocarpa
WO2010027221A3 (en) * 2008-09-04 2010-07-15 재단법인 제주하이테크산업진흥원 Skin-whitening composition comprising an extract, fraction or compound derived from lindera erythrocarpa
KR20240019987A (en) 2022-08-05 2024-02-14 동의대학교 산학협력단 Antibacterial composition containing field aster extract and antibacterial or deodorizing composition containing same
KR20240020237A (en) 2022-08-05 2024-02-14 동의대학교 산학협력단 Composition for antibacterial and anti-inflammatory comprising extract of coastal hogfennel, and composition for preventing or improving asthma, eczema and rhinitis comprising the same

Also Published As

Publication number Publication date
KR100387939B1 (en) 2003-06-27

Similar Documents

Publication Publication Date Title
Mohammadhosseini The ethnobotanical, phytochemical and pharmacological properties and medicinal applications of essential oils and extracts of different Ziziphora species
Shah et al. Piper betle: Phytochemical, pharmacological and nutritional value in health management
Sabandar et al. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): a review
Abad et al. Baccharis (Compositae): a review update
EP2030626B1 (en) Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
Rajvaidhya et al. A review on Acacia Arabica-an Indian medicinal plant
US6616943B2 (en) Composition comprising Wenguanguo extracts and methods for preparing same
Pandey et al. Essential oil compositions, pharmacological importance and agro technological practices of Patchouli (Pogostemon cablin Benth.): A review
Najjaa et al. Aromatic and medicinal plants of Tunisian arid and desert zone used in traditional medicine, for drug discovery and biotechnological applications
KR20020008809A (en) Fungicide composition containing extracts derived from plant
Mohanty et al. A review on therapeutic potential of Artemisia nilagirica
Arora et al. Cinnamon: a clinical approach as multifarious natural remedy with absolute immunity
Mansour-Djaalab et al. In vitro evaluation of antifungal effects of Lawsonia inermis, Pistacia lentiscus and Juglans regia.
Mohammed et al. Phytochemical analysis and anti-microbial activities of Artemisia spp. and rapid isolation methods of artemisinin
Mohamed et al. Chemical and biological studies on Moringa oleifera L. cultivated in Egypt
KR100387939B1 (en) Fungicide composition containing extracts derived from plant
KR100427584B1 (en) Fungicide composition containing extracts derived from plant
Dongare et al. A Review on Pogostemon patchouli
KR100437576B1 (en) Fungicide composition containing cinnamylalcohol
Rauf et al. Pharmacological investigation of genus Pistacia
KR100807809B1 (en) Antimicrobial composition which comprising the Hibiscus ethanol extract
CN113713003A (en) Folium artemisiae argyi extract and preparation method and application thereof
Mangawang et al. Phytochemical screening of fish poison tree, Barringtonia asiatica seed for potential biopesticidal activity and pharmaceutical uses
KR100649121B1 (en) Complex antifungal agents as an effective gredient comprising essential oil compounds from Agastache rugosa and ketoconazole
WO2003035093A1 (en) Antibacterial composition comprising plant extract

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130614

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20140603

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee